Effect of nitrogen on carbon dioxide elimination during continuous flow apneic ventilation in dogs

Non-toxic alveolar oxygen concentration without hypoxemia during apnoeic oxygenation: an experimental study

BACKGROUND

Oxygenation without tidal breathing, i.e. apnoeic oxygenation in combination with extracorporeal carbon dioxide removal, might be an option in the treatment of acute respiratory failure. However, ventilation with 100% O₂, which is potentially toxic, is considered a prerequisite to ensure acceptable oxygenation. We hypothesized that trapping nitrogen (N₂) in the lungs before the start of apnoeic oxygenation would keep the alveolar O₂ at a non-toxic level and still maintain normoxaemia. The aim was to test whether a predicted N₂ concentration would agree with a measured concentration at the end of an apnoeic period.

METHODS

Seven anaesthetized, muscle relaxed, endotracheally intubated pigs (22-27 kg) were ventilated in a randomized order with an inspired fraction of O₂ 0.6 and 0.8 at two positive end-expiratory pressure levels (5 cm and 10 cm H₂O) before being connected to continuous positive airway pressure using 100% O₂ for apnoeic oxygenation. N₂ was measured before the start of and at the end of the 10-min apnoeic period. The predicted N₂ concentration was calculated from the initial N₂ concentration, the end-expiratory lung volume, and the anatomical dead space.

RESULTS

The mean difference and standard deviation between measured and predicted N₂ concentration was -0.5 ± 2%, P = 0.587. No significant difference in the agreement between measured and predicted N₂ concentrations was seen in the four settings.

CONCLUSIONS

This study indicates that it is possible to predict and keep alveolar N₂ concentration at a desired level and, thus, alveolar O₂ concentration at a non-toxic level during apnoeic oxygenation.

Continuous-flow apneic ventilation with small endobronchial catheters

This study compares gas exchange and hemodynamic parameters during bronchial insufflation with two different internal diameter (ID) catheters (2.5 and 1.4 mm) at a constant mean gas exit velocity. Anesthetized, paralyzed dogs were instrumented to monitor arterial, central venous, and airway pressures, blood gases, temperature, ECG, and ventilated using continuous flow apneic ventilation (CFAV) via 2.5-mm or 1.4-mm ID bronchial insufflation catheters positioned 1.25 bronchial diameter units (BDU) beyond the carina. Initially, flow was adjusted to provide adequate oxygenation and ventilation through the 2.5-mm ID catheters. After a 30-min stabilization, physiological parameters were recorded and the mean gas exit velocity was calculated. The 2.5-mm ID insufflation catheters were then replaced by 1.4-mm ID catheters and the bronchial insufflation flow adjusted so as to produce the same mean gas exit velocity as for the 2.5-mm ID catheters. After a 30-min stabilization period, physiological parameters were again recorded. No significant differences were noted in arterial, central venous, or airway pressures, temperature, heart rate, pH, PaCO2, and PaO2 between the 2.5-mm and 1.4-mm ID bronchial insufflation catheters. However, significantly less bronchial insufflation flow (69.7%) was required to maintain oxygenation and ventilation for the 1.4-mm ID bronchial insufflation catheters.